Combination Therapy for Psoriasis with Methotrexate and Other Oral Disease-Modifying Antirheumatic Drugs: A Systematic Review

INTRODUCTION: Although the introduction of biologics and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs) has reshaped the treatment paradigm for immune-mediated inflammatory diseases (IMIDs) such as psoriasis, oral conventional synthetic DMARDs (csDMARDs) remain the cornerstone i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Tyng-Shiuan, Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060456/
https://www.ncbi.nlm.nih.gov/pubmed/36943580
http://dx.doi.org/10.1007/s13555-023-00903-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060456/
https://www.ncbi.nlm.nih.gov/pubmed/36943580
http://dx.doi.org/10.1007/s13555-023-00903-5

Ejemplares similares